A randomized control trial to assess efficacy of Mifepristone in medical management of uterine fibroid

Mifepristone when given in bi-weekly doses was found to be safe, efficacious, and cost effective as compared to treatment with tranexemic acid and mefenemic acid for management of fibroid uterus.